Karl Ehlerding looks back at over 60 years of stock market experience. The equity investor is truly unique among investors – in Germany, and probably worldwide.
Karl Ehlerding blickt zurück auf über sechs Jahrzehnte Börsenerfahrung. Der erfolgreiche Aktienanleger ist ein echtes Unikat der deutschen Aktienszene.
Switzerland’s famous chocolate brand, Lindt & Sprüngli, has a six-digit share price. How did the stock reach such heights, and does it have further to run?
London-listed Polymetal gets you a stake in Russian gold mining for the proverbial song. Crisis investing at its best!
Anyone who owns Depositary Receipts of Russian stocks has been stuck with illiquid securities. Are there any solutions in sight?
Institutional investors are paying top dollars to pick Jens Nordvig’s brain. His research and analysis firm, Exante Data, uncovers macro trends ahead of the crowd.
The stock of Marshall Group has recently seen unusually large transactions. Could the company’s massive land bank soon drive the share price to new heights?
Capturing gas from old coal mines can be a surprising money spinner. How does it work, and what’s the further outlook?
ZCCM Investments Holdings is a Paris-listed company that time forgot. In recent weeks, the stock price has started to rally. Are exciting changes afoot?
Insecurity Analysis helps you learn from great investors. Its truly unique approach involves dusty archives and long-forgotten material.
The weak pound sterling makes British companies even cheaper for foreign bidders. What are the likely bid targets?
Russia’s ruble was supposed to turn into “rubble”, but it became a “double” instead. How does this impact private investors?
EarthLabs is a world-leading digital platform for the mining business. Its stock appears almost ludicrously cheap. Does it hold up to scrutiny?
Demand from Big Pharma has turned radium into the world’s hottest commodity. A remarkable investment opportunity awaits.
Nasdaq-listed Alico owns large tracts of land in Florida. Will the state’s influx of residents finally get the stock moving?
This AIM-listed small-cap will likely return all its capital to shareholders. Underresearched by investors, it's an opportunity that shouldn't even exist – but it does.
If or when the war in Ukraine ends, this stock will likely become the focus of investor money pushing into the country.
This little-known Western European company could become the global market leader for supplying the uber-rare "Ac-225", a potent weapon to treat cancer.
